Experimental and quantitative imaging techniques in interstitial lung disease
ND Weatherley, JA Eaden, NJ Stewart, BJ Bartholmai… - Thorax, 2019 - thorax.bmj.com
Interstitial lung diseases (ILDs) are a heterogeneous group of conditions, with a wide and
complex variety of imaging features. Difficulty in monitoring, treating and exploring novel …
complex variety of imaging features. Difficulty in monitoring, treating and exploring novel …
Assessment of disease outcome measures in systemic sclerosis
R Lafyatis, E Valenzi - Nature Reviews Rheumatology, 2022 - nature.com
The assessment of disease activity in systemic sclerosis (SSc) is challenging owing to its
heterogeneous manifestations across multiple organ systems, the variable rate of disease …
heterogeneous manifestations across multiple organ systems, the variable rate of disease …
18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
E Ledoult, M Morelle, M Soussan, A Mékinian… - Arthritis Research & …, 2021 - Springer
Background Interstitial lung disease is a common complication of systemic sclerosis (SSc-
ILD), and it remains difficult to accurately predict its course. Progressing ILD could be more …
ILD), and it remains difficult to accurately predict its course. Progressing ILD could be more …
The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients
DM Peelen, BGJC Zwezerijnen, EJ Nossent… - …, 2020 - academic.oup.com
Objectives The reversibility of interstitial lung disease (ILD) in SSc is difficult to assess by
current diagnostic modalities and there is clinical need for imaging techniques that allow for …
current diagnostic modalities and there is clinical need for imaging techniques that allow for …
[HTML][HTML] Novel tracers for molecular imaging of interstitial lung disease: A state of the art review
B Broens, JW Duitman, GJC Zwezerijnen… - Autoimmunity …, 2022 - Elsevier
Interstitial lung disease is an overarching term for a wide range of disorders characterized by
inflammation and/or fibrosis in the lungs. Most prevalent forms, among others, include …
inflammation and/or fibrosis in the lungs. Most prevalent forms, among others, include …
Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2
J Schniering, M Benešová, M Brunner… - Annals of the …, 2019 - ard.bmj.com
Objective To evaluate integrin αvβ3 (alpha-v-beta-3)-targeted and somatostatin receptor 2
(SSTR2)-targeted nuclear imaging for the visualisation of interstitial lung disease (ILD) …
(SSTR2)-targeted nuclear imaging for the visualisation of interstitial lung disease (ILD) …
18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease
Y Zhang, Z Chen, Y Long, B Zhang, Q He, K Tang… - Clinical …, 2022 - Springer
Objectives Rapidly progressive interstitial lung disease (RP-ILD) is a life-threatening form of
idiopathic inflammatory myopathy (IIM)-associated interstitial lung disease (ILD). We aimed …
idiopathic inflammatory myopathy (IIM)-associated interstitial lung disease (ILD). We aimed …
Pulmonary functional imaging (PFI): A historical review and perspective
G Bozovic, CM Schaefer-Prokop… - Acta …, 2023 - journals.sagepub.com
PFI Pulmonary Functional Imaging (PFI) refers to visualization and measurement of
ventilation, perfusion, gas flow and exchange as well as biomechanics. In this review, we …
ventilation, perfusion, gas flow and exchange as well as biomechanics. In this review, we …
Overview of positron emission tomography in functional imaging of the lungs for diffuse lung diseases
AV Gulhane, DL Chen - The British Journal of Radiology, 2022 - academic.oup.com
Positron emission tomography (PET) is a quantitative molecular imaging modality
increasingly used to study pulmonary disease processes and drug effects on those …
increasingly used to study pulmonary disease processes and drug effects on those …
ACR Appropriateness Criteria® chronic dyspnea-noncardiovascular origin
BL McComb, JG Ravenel, RM Steiner… - Journal of the American …, 2018 - Elsevier
Chronic dyspnea may result from a variety of disorders of cardiovascular, pulmonary,
gastrointestinal, neuromuscular, systemic, and psychogenic etiology. This article discusses …
gastrointestinal, neuromuscular, systemic, and psychogenic etiology. This article discusses …